Treatment Effectiveness
User reported effectiveness ratings Coenzyme Q10 for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Adrenal Fatigue | 0% | 38% | 0% | 63% | 0% | 16 |
| Chronic Fatigue Syndrome | 4% | 22% | 3% | 68% | 4% | 296 |
| Fibromyalgia | 2% | 19% | 2% | 75% | 2% | 140 |
| Migraine | 2% | 12% | 1% | 82% | 2% | 274 |
| Mitral Valve Prolapse | 10% | 12% | 2% | 74% | 2% | 105 |
| Fatigue | 2% | 16% | 3% | 75% | 3% | 485 |
Side Effects
User-reported side effects of Coenzyme Q10
| Side Effect | Percent of Reports Coenzyme Q10 |
|---|---|
| Heartburn | 9% |
| Migraine | 0% |
| Dizziness | 8% |
| Feeling Irritable | 11% |
| Feeling Sensitive to Light | 8% |
| Feeling Very Tired | 16% |
| Pain in the Upper Part of the Abdomen | 7% |
| Rashes | 3% |
| Headache | 9% |
| Insomnia | 12% |
| Nausea | 7% |
Outcomes
Below is the degree of change seen after Coenzyme Q10 is higher than average.
|
|
Outcomes Label
Coenzyme Q10 Info
| Property | Value |
|---|---|
| Variable Name | Coenzyme Q10 |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-25 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 92973 |